The short version:
Matt’s platelet level has been low and the docs and us are trying to figure out why. Matt’s been in a better mood these last few weeks.
The long version:
Sloan Kettering is currently rated as the top cancer treatment facility in the country and possibly the world. Matt's appointment there was scheduled for 2 p.m. on Tuesday, October 7. We registered mid-morning and also went up to the doctor’s office to let the staff know we had done so. I should mention that the doctor we were scheduled to see, Dr. Nimer, is the head of the hematology department at SK. When we returned for the appointment, Matt was told to go into a room for a blood test. We were ushered into an examining room 20 or 30 minutes after that. A visiting physician from Italy, accompanied by an intern, interviewed Matt and gave him a brief physical exam. Fifteen or twenty minutes after that, Dr. Nimer came with the other two docs, talked with Matt, and made his recommendations. He allowed ample time for Matt and me to ask questions.
On our way out, Matt asked the receptionist for a copy of the lab results. He noticed that his platelet level had gone down to 27, significantly lower than at any time since his diagnosis. His initial platelet level had been around 67 and the most recent California lab test had shown a platelet level of 138.
During the consultation, Dr. Nimer had said that Matt's lab tests showed that the Hydrea he'd been taking was working. He'd also commented that this was unusual since this drug often causes the platelet level to go down. With the revelation of a platelet level of 27, Matt and I obviously had major questions. Matt spoke to Dr. Nimer's nurse. She told him that Dr. N would look at the test results and get back to him. About an hour later, someone from Dr. N's office called and told Matt that he should go to Urgent Care the following day to get a transfusion. Flying with a platelet level below 50 is dangerous, he was told.
Sooooooo, we returned the next day with many questions, one of which was: Did Dr. N even look at the lab test that HE has ordered? And, if not, how valid were the recommendations that he had made at the previous day? Dr. N was not scheduled to come in, his nurse told us, but she would call him. Meanwhile, it was important that Matt get the transfusion done.
The process of getting the transfusion going involved a number of steps and a bit of a wait. At one point, we were told that we could go the hospital cafeteria. As we returned from lunch, we ran into Dr. N. He'd returned to the hospital and was looking for Matt. We sat in the corner of a waiting room and discussed the situation with him. The SK test results weren't available before yesterday's appointment, Dr. N told us. The SK test results changed everything. As the 3 of us talked, Dr. N. came to the conclusion that Matt's higher platelet level was probably due to his taking Prednisone for his gout. The lower platelet level was due to both the Hydrea and Matt's discontinuing the Prednisone after he'd completed the course of treatment. Dr. N told us his revised recommendations and that he'd be in touch with Matt's California oncologist. He also gave us his personal cell phone number.
Unfortunately Dr. N. was unable to call Dr. Anderson, Matt's regular hematologist/oncologist before his appointment on Monday, October 23. Matt had mistakenly given him the wrong number. The doctors were apparently playing phone tag on Tuesday when Matt saw another h/o in the Kaisar system. Dr. Anderson had set up this consultation with Dr. Lake because of his more lengthy experience dealing with the disease.
Both Kaisar doctors advocate an approach that is basically "wait and see," weekly blood tests with no pharmacological treatment. They point out that Matt is currently symptom free and that there is no treatment for his type of leukemia (CMML). Dr. Lake said that the Hydrea Matt has been taking can show "cosmetic" improvement, i.e. more normal red and white blood cell levels, but that it doesn't really affect the disease itself. The biggest issue right now is the low level of Matt's platelets. This could be caused by the Hydrea, by the leukemia, or by an unrelated process by which Matt's body is destroying its own platelets. Matt sees a correlation between his platelet levels and his use of Prednisone for his gout. Both Kaisar doctors discount this, but have agreed to Matt's request to see if Dexamethasone elevates his platelet level. Dex is a steroid and is similar, but stronger, than Prednisone. As it stands now, Matt embarked on a four day Dex treatment, using huge doses of the drug, today. He's not taking the Hydrea, but would like to use it in smaller doses than he'd been taking it once his platelet level has risen. He's also taking some cancer fighting herbs, something Dr. Nimer had discouraged. Interestingly, Dr. Lake told us that he thought the platelet transfusion was unnecessary. He said that the actual platelets in a patient with a low platelet level are individually more powerful because they are younger. I wonder about this even though Dr. Lake seemed highly competent to me.
I'm writing this on Friday, October 27. Matt had another blood test this morning. His platelet level had fallen to 32. (He's able to get the result on line.) Last Friday, the platelet level was 47. It will be interesting to see the result of next Friday's test.
A word about Matt's mood: He seems more upbeat and optimistic than he'd been in the early weeks after his diagnosis. Also happier. He's been experiencing some back pain and some pain in his wrist. Nothing agonizing, like the gout. That helps. Also the beautiful California weather that we've been experiencing. Tomorrow we'll go together to the farmer's market and then to Costco and Trader Joes. We may see a movie on Sunday. Small pleasures. During our consultation with Dr. Lake, I asked if he could check back over past lab tests. A quick check of Matt's records, stored on some Kaisar computer file, revealed that there were some signs of his having the disease as early as 2003. The level of the cancer cells a year ago was about the same as it is right now. To me this suggests that the cancer is proceeding slowly. On the other hand, it might also suggest that Matt is further along in the disease process than we'd thought. On one hand, I look at how Matt was able to enjoy his life in the ignorance of what his body was doing. Since there is currently no cure for the disease, Matt has paid no penalty for this prior ignorance. On the other hand, is there value in the knowing?